BRNS 8-K 2026-08-25

Barinthus Biotherapeutics plc. (BRNS) 8-K dated 2026-08-25 — accession 0001104659-26-100470. This URL is the filing, not the BRNS hub.

Barinthus Biotherapeutics plc. (BRNS) is a biotechnology company listed on US.

Barinthus Biotherapeutics plc. filed a 8-K on 2026-08-25. Accession 0001104659-26-100470.

Cached items: 3.01, 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.

Not investment advice. The BRNS SEC hub lists recent forms. The stock page is the research view.